Delivery Order SPE2DB22D3019-SPE2DB25FK4EB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,140.70 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract type. This competitive award, issued on August 28, 2025, with an ultimate completion date of August 29, 2025, carries no set-aside designation. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $22,046.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $21,753.83 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,146.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $13,387.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing one...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $11,743.92. This firm fixed price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK4EBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,237.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the Defense Logistics Agency's medical supply chain operations supporting military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, competes for federal medical procurement requirements through open competition and maintains capability to fulfill diverse federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 9/3/25 |